ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Accuracy Of Diagnostic Mammograms Varies By Radiologist, Study Finds

December 28, 2007

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

NEJM Paper Ignites Debate Over Spiral CT Scans For Lung Cancer.

November 3, 2006

Professional Issues: AMA Identifies Tobacco-Free Mutual Funds

February 21, 1997